N/A
N=48
Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men
Inactivity
Bottom Line
View on ClinicalTrials.gov: NCT02512419 ↗Enrolled (actual)
48
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Objectively Measured Physical Activity of at Least Moderate Intensity (MVPA) by the Actigraph GT3X+ — 10; 21; 57.5; 23 minutes/week — p=.04
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Text-Enhanced Physical Activity Intervention Arm (Behavioral); Health Education Control Arm (Behavioral); Actigraph GT3X (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- University of California, San Diego
- Primary completion
- Oct 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Objectively Measured Physical Activity of at Least Moderate Intensity (MVPA) by the Actigraph GT3X+ |
10; 21; 57.5; 23 | .04 sig |
| PRIMARY Self Reported Min/Week of MVPA |
10; 5; 95; 52.5 | 0.10 |
Summary
The aim of this study is to build upon our tailored print intervention by developing new text-delivered intervention materials to complement our print-based physical activity (PA) intervention. In Phase 1 we will conduct 6 focus groups with Mexican and Mexican American (MA) men to determine content, frequency, and types of text messages desired, and to identify cultural themes to incorporate into existing and new materials. Themes from the focus groups and sample text messages will be presented to a confirmatory focus group panel. Phase 2 will be a 6-month pilot randomized controlled trial with Mexican and MA men (N=60) to test the text-enhanced, Spanish language, individually tailored PA intervention vs. publicly available, Spanish language health education materials, including information on PA, diet, and stress management. This will be followed by post-intervention qualitative interviews to solicit suggestions for improvements to help further refine the program. The proposed pilot will support a future R01 to establish the efficacy of this multi-media, multi-level PA intervention for Mexican and MA men.
Eligibility Criteria
Inclusion Criteria
- Male
- Generally healthy (If asthma, controlled high blood pressure and/or controlled type II diabetes, may be able to participate with physician consent)
- Sedentary (Less than 60 minutes per week of moderate or vigorous physical activity)
- Mexican and/or Mexican American (self-identified)
- Must be able to read and write Spanish fluently
- 18 - 65 years of age
- Planning on living in the area for the next 6 months
- Own a cell phone capable of sending and receiving text messages
Exclusion Criteria
- Body Mass Index(BMI) greater than 45
- Not able to walk continuously for 30 minutes/limited ability to complete daily activity or ability to exercise
- Exercise is against advice of doctor
- Heart disease/treatment
- Heart murmur
- Angina/chest pain or Angina/chest pain with exertion
- Palpitations
- Stroke/Transient Ischemic Attacks
- Peripheral Vascular Disease
- Type I Diabetes
- Uncontrolled Type II Diabetes
- Chronic Infectious Disease - HIV, Hepatitis
- Chronic liver disease
- Cystic Fibrosis
- Abnormal EKG on last EKG performed
- Emphysema, Chronic bronchitis, Chronic Obstructive Pulmonary Disease
- Seizure in past year
- Surgery in past year on heart, lung, joint, orthopedic surgery
- Surgery pending in next year on lung, joint, orthopedic surgery
- Unusual/concerning shortness of breath
- Asthma (may be able to participate with physician consent)
- High blood pressure/high blood pressure medication (may be able to participate with physician consent)
- Use of beta blockers
- Abnormal Medical Stress Test
- Musculoskeletal problems
- Fainting/dizziness more than 3 times in past year OR interferes with daily activities OR causes loss of balance
- Cancer treatment in past 3 months
- Hospitalized for psychiatric disorder in past 3 years or suicidal
Data sourced from ClinicalTrials.gov (NCT02512419). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.